Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Owc Pharmaceutical Research Corp (OWCP)

Owc Pharmaceutical Research Corp (OWCP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.22
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0071 unch
on 11/12/19
0.0095 -25.26%
on 10/14/19
-0.0020 (-21.98%)
since 10/11/19
3-Month
0.0066 +7.58%
on 08/22/19
0.0148 -52.03%
on 10/03/19
-0.0048 (-40.34%)
since 08/12/19
52-Week
0.0066 +7.58%
on 08/22/19
0.1850 -96.16%
on 01/07/19
-0.1504 (-95.49%)
since 11/12/18

Most Recent Stories

More News
OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-based Tablets

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced today that, on September 25, 2019,...

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-based Tablets

RAMAT GAN , Israel , Oct. 7, 2019 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions...

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial

RAMET GAN, Israel , Aug. 5, 2019 /PRNewswire/ --  OWC   Pharmaceuticals Research Corp.  ("OWC") (OTCQB: OWCP) announced that, on July 18, 2019 , it received long-awaited...

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial

OWC Pharmaceuticals Research Corp. ("OWC") (OTCQB: OWCP) announced that, on July 18, 2019, it received long-awaited approval from the Israeli Medical Cannabis Agency to perform an efficacy study with OWC...

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets

OWC Pharmaceutical Research Corp. (OTCQB: OWCP) (http://owcpharma.com/), the company transforming cannabis into scientifically proven and clinically approved medical solutions, announces...

OWCP : 0.0071 (-2.74%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

ACRGF : 4.8200 (-1.63%)
ALEAF : 0.6197 (-10.19%)
ARREF : 0.4020 (+1.52%)
CWBHF : 10.0500 (-5.63%)
CORVF : 1.4216 (+3.01%)
CRLBF : 6.3775 (-0.66%)
DYAI : 5.81 (-2.52%)
ELLXF : 0.8900 (-3.26%)
EMHTF : 0.5000 (-3.85%)
GLDLF : 0.7229 (-2.31%)
GTBIF : 8.4191 (+1.93%)
GRWG : 4.4300 (-3.70%)
HEOFF : 0.7988 (-0.09%)
ITHUF : 1.3599 (-5.56%)
IMLFF : 0.2080 (-7.76%)
ISYRF : 1.1500 (unch)
MMNFF : 1.0500 (-3.76%)
MTAFF : 1.0125 (-0.74%)
MJARF : 0.4400 (-5.68%)
NUPMF : 3.2100 (-0.62%)
NLST : 0.3450 (+1.47%)
STLHF : 0.5113 (-0.91%)
TRLFF : 0.0930 (+3.33%)
AITB : 5.24 (+2.34%)
ALYE : 1.3500 (unch)
ARTH : 0.1624 (-0.06%)
ARHH : 1.5900 (+7.76%)
ATEA : 11.5800 (+0.26%)
BICXD : 4.5400 (-9.02%)
BRTI : 0.1345 (-3.58%)
CNBX : 0.1300 (-3.56%)
CLOK : 0.7200 (+10.77%)
CVSI : 1.5300 (-10.26%)
DUOT : 0.4800 (unch)
EVLLF : 1.0400 (-5.45%)
FLUX : 8.0000 (-13.04%)
GBPT : 7.0000 (-12.50%)
GTBP : 0.1600 (-2.14%)
KSHB : 1.7201 (-3.37%)
MRMD : 0.8809 (+0.79%)
MLCPF : 3.5200 (+11.47%)
MRIC : 4.10 (+1.99%)
NMUS : 0.6500 (-9.52%)
NWGI : 0.3490 (-0.29%)
OWCP : 0.0071 (-2.74%)
PPCB : 0.3950 (+6.76%)
QBIO : 0.4400 (+11.39%)
RSSS : 3.1300 (-2.19%)
VTLR : 0.0598 (-8.00%)
WIZD : 0.0800 (-3.03%)
OTCM : 34.4000 (+0.88%)
OWC Pharmaceutical Research Corp, Letter to Shareholders

RAMAT GAN, Israel, Feb. 11, 2019 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and...

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Corp, Letter to Shareholders

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a letter to shareholders.

OWCP : 0.0071 (-2.74%)
OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial for Medical Grade Cannabis Ointment for Treatment of Skin Diseases

RAMAT GAN , Israel , Jan. 30, 2019 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions...

OWCP : 0.0071 (-2.74%)
ETFs & Stocks From Top-Ranked Sector to Buy

Investors could be well served by ETFs and stocks from sectors that house top-ranked industries.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade OWCP with:

Key Turning Points

2nd Resistance Point 0.0080
1st Resistance Point 0.0077
Last Price 0.0071
1st Support Level 0.0071
2nd Support Level 0.0068

See More

52-Week High 0.1850
Fibonacci 61.8% 0.1169
Fibonacci 50% 0.0958
Fibonacci 38.2% 0.0747
Last Price 0.0071
52-Week Low 0.0066

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar